As of 2025-07-03, the Relative Valuation of Gemini Therapeutics Inc (GMTX) is (14.54) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 USD, the upside of Gemini Therapeutics Inc based on Relative Valuation is -1176.7%.
The range of the Relative Valuation is (14.22) - (20.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 18.7x | 13.2x |
| Forward P/E multiples | 12.8x - 21.2x | 13.7x |
| Fair Price | (14.22) - (20.19) | (14.54) |
| Upside | -1153.5% - -1595.4% | -1176.7% |
| Date | P/E |